| Trial | NCT02568241 | NCT02185261 | |
|---|---|---|---|
| Enrolled time post allo-SCT: months median(range) | 13.4(3.6-73.5) | 4.1(2.9-26.3) | |
| DLI within 2 months % (n) | 100% (n = 5) | 23.8% (n = 5) | |
| Intervention weeks | 10(9-16) | 10(1-22) | |
| ORR % (n) | 100%(n = 5) | 95.2%(n = 18) | |
| ORR weeks median(range) | 3(2-4) | 3(2-7) | |
| Best Response | MRD- | 80%(n = 4) | 85.7% (n = 18) |
| Best Response | CR with MRD reduction | 20%(n = 1) | 9.5% (n = 2) |
| Best Response weeks median(range) | 6(3-9) | 5(2-18) | |
| Maintaining Response weeks median(range) | 13 (6-38.7) | 28 (3-90) | |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.